{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:27:52Z","timestamp":1789457272450,"version":"build-2803163510"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"National Agency for Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1221098"],"award-info":[{"award-number":["1221098"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.plefa.2025.102686","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:15:25Z","timestamp":1748344525000},"page":"102686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Impact of n-3 polyunsaturate fatty acids supplementation on visual health throughout the life cycle: A systematic review"],"prefix":"10.1016","volume":"206","author":[{"given":"Claudia","family":"Tabilo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Squella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Illesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasna","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Far\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-6142","authenticated-orcid":false,"given":"Rodrigo","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0001","doi-asserted-by":"crossref","first-page":"761","DOI":"10.15446\/revfacmed.v64n4.53684","article-title":"Aceites y grasas: efectos en la salud y regulaci\u00f3n mundial","volume":"64","author":"Constanza","year":"2016","journal-title":"Rev. Fac. Med"},{"key":"10.1016\/j.plefa.2025.102686_bib0002","first-page":"66","volume":"29","author":"Esther","year":"2010"},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0003","first-page":"457","article-title":"Mecanismos moleculares de acci\u00f3n de los \u00e1cidos grasos poliinsaturados y sus beneficios en la salud","volume":"57","author":"Maricela","year":"2005","journal-title":"Rev. Invest. Cl\u00edn."},{"issue":"25","key":"10.1016\/j.plefa.2025.102686_bib0004","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4321\/S1695-61412012000100022","article-title":"Funcionalidad y recomendaciones nutricionales de \u00e1cidos grasos esenciales y sus derivados en la alimentaci\u00f3n del lactante a partir de los 6 meses de edad","volume":"11","author":"Matencio Hilla","year":"2012","journal-title":"Enferm. Glob."},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4067\/S0717-75182011000300011","article-title":"\u00c1cidos grasos \u03c9-3 PUFA (EPA y DHA) y su aplicaci\u00f3n en diversas situaciones cl\u00ednicas","volume":"38","author":"Rodrigo","year":"2011","journal-title":"Rev. Chil. Nutr."},{"key":"10.1016\/j.plefa.2025.102686_bib0006","first-page":"1","article-title":"Protein concentrations and activities of fatty acid desaturase and elongase enzymes in liver, brain, testicle, and kidney from mice: substrate dependency","author":"Valenzuela","year":"2023","journal-title":"Biofactors"},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0007","first-page":"2236","article-title":"Fuentes alimentarias y adecuaci\u00f3n de la ingesta de \u00e1cidos grasos \u03c9-3 PUFA y omega-6 en una muestra representativa de adultos espa\u00f1oles","volume":"28","author":"Ortega Anta Rosa","year":"2013","journal-title":"Nutr. Hosp."},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0008","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4067\/S0717-75182012000300012","article-title":"Nuevas fuentes dietarias de acido alfa-linol\u00e9nico: una visi\u00f3n cr\u00edtica","volume":"39","author":"Jessica","year":"2012","journal-title":"Rev. Chil. Nutr."},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0009","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/ajcn\/83.6.1483S","article-title":"Healthy intakes of n\u22123 and n\u20136 fatty acids: estimations considering worldwide diversity","volume":"83","author":"Hibbeln","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0010","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4067\/S0717-75182015000300013","article-title":"Las microalgas: una fuente renovable para la obtenci\u00f3n de \u00e1cidos grasos \u03c9-3 PUFA de cadena larga para la nutrici\u00f3n humana y animal","volume":"42","author":"Alfonso","year":"2015","journal-title":"Rev. Chil. Nutr."},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0011","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4067\/S0717-75182014000300014","article-title":"\u00c1cidos grasos poliinsaturados de cadena larga \u03c9-3 y enfermedad cardiovascular","volume":"41","author":"Rodrigo","year":"2014","journal-title":"Rev. Chil. Nutr."},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0012","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4067\/S0717-75182013000400009","article-title":"\u00c1cido docosahexaenoico (DHA), un \u00e1cido graso esencial a nivel cerebral","volume":"40","author":"Rodrigo","year":"2013","journal-title":"Rev. Chil. Nutr."},{"key":"10.1016\/j.plefa.2025.102686_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108440","article-title":"The essential role of docosahexaenoic acid and its derivatives for retinal integrity","volume":"247","author":"Swinkels","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0014","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1194\/jlr.P065540","article-title":"Associations of human retinal very long-chain polyunsaturated fatty acids with dietary lipid biomarkers","volume":"57","author":"Gorusupudi","year":"2016","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.plefa.2025.102686_bib0015","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/antiox9100920","article-title":"Protective effects and molecular signaling of n-3 fatty acids on oxidative stress and inflammation in retinal diseases","volume":"9","author":"Suzumura","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"29","key":"10.1016\/j.plefa.2025.102686_bib0016","doi-asserted-by":"crossref","first-page":"12054","DOI":"10.1074\/jbc.M117.790568","article-title":"Docosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cells","volume":"292","author":"Shindou","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.plefa.2025.102686_bib0017","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4321\/S0365-66912008000700002","article-title":"Implicaciones de los \u00e1cidos grasos en la salud ocular [Implications of fatty acids in ocular health]","volume":"83","author":"Pinazo-Dur\u00e1n","year":"2008","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"},{"issue":"10","key":"10.1016\/j.plefa.2025.102686_bib0018","first-page":"1203","article-title":"Acido docosahexaenoico (DHA) en el desarrollo fetal y en la nutrici\u00f3n materno-infantil","volume":"129","author":"Alfonso","year":"2001","journal-title":"Rev. M\u00e9d. Chile."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0019","first-page":"50","article-title":"Componentes nutricionales y degeneraci\u00f3n macular relacionada con la edad","volume":"32","author":"Antonio","year":"2015","journal-title":"Nutr. Hosp."},{"issue":"9","key":"10.1016\/j.plefa.2025.102686_bib0020","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"Declaraci\u00f3n PRISMA 2020: una gu\u00eda actualizada para la publicaci\u00f3n de revisiones sistem\u00e1ticas","volume":"74","author":"Page","year":"2021","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control. Clin. Trials"},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0022","first-page":"296","article-title":"Are \u03c9-3 fatty acids required for normal eye and brain development in the. human?","volume":"11","author":"Uauy","year":"1990","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0023","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0006-291X(72)90403-2","article-title":"High content of docosahexaenoate and of total diacylglycerol in retina","volume":"48","author":"Avelda\u00f1o","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"10.1016\/j.plefa.2025.102686_bib0024","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.0402531101","article-title":"Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress","volume":"101","author":"Mukherjee","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1750-3639.2005.tb00513.x","article-title":"Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress","volume":"15","author":"Bazan","year":"2005","journal-title":"Brain Pathol."},{"key":"10.1016\/j.plefa.2025.102686_bib0026","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000351395","article-title":"Docosahexaenoic acid and its derivative neuroprotectin D1 display neuroprotective properties in the retina, brain and central nervous system","volume":"77","author":"Bazan","year":"2013","journal-title":"Nestle Nutr. Inst. Workshop. Ser."},{"issue":"10","key":"10.1016\/j.plefa.2025.102686_bib0027","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.3390\/nu12103114","article-title":"Efficient enrichment of retinal DHA with dietary lysophosphatidylcholine-DHA: potential application for retinopathies","volume":"12","author":"Sugasini","year":"2020","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0028","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1167\/iovs.02-0901","article-title":"Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors","volume":"44","author":"Rotstein","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0029","first-page":"303","article-title":"Effect of infant diets with different polyunsaturated to saturated fat ratios on circulating high-density lipoproteins","volume":"1","author":"Carlson","year":"1982","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3476(06)80734-1","article-title":"Lessons learned from randomizing infants to marine oil-supplemented formulas in nutrition trials","volume":"125","author":"Carlson","year":"1994","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0031","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4067\/S0717-75182018000100080","article-title":"Morales Gladys I. Efectos neuroprotectores del \u00e1cido araquid\u00f3nico y del \u00e1cido docosahexaenoico en las etapas extremas de la vida: una visi\u00f3n integradora","volume":"45","author":"Orellana","year":"2018","journal-title":"Rev. Chil. Nutr."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0032","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.preteyeres.2004.06.002","article-title":"The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina","volume":"24","author":"SanGiovanni","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"issue":"8","key":"10.1016\/j.plefa.2025.102686_bib0033","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/10715760600719557","article-title":"Effect of docosahexaenoic acid intake on lipid peroxidation in diabetic rat retina under oxidative stress","volume":"40","author":"Sunada","year":"2006","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.plefa.2025.102686_bib0034","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jphotobiol.2014.07.016","article-title":"Docosahexaenoic acid aggravates photooxidative damage in retinal pigment epithelial cells via lipid peroxidation","volume":"140","author":"Liu","year":"2014","journal-title":"J. Photochem. Photobiol. B"},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3945\/jn.110.128215","article-title":"Auditory- and visual-evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg\/d docosahexaenoic acid in the second half of pregnancy","volume":"141","author":"Stein","year":"2011","journal-title":"J. Nutr."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0036","first-page":"558","article-title":"Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial","volume":"87","author":"Smithers","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0037","first-page":"2545","article-title":"Effects of maternal \u03c9-3 supplementation on fatty acids and on visual and cognitive development","volume":"32","author":"Hurtado","year":"2015","journal-title":"Nutr. Hosp."},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0038","first-page":"943","article-title":"Kerling EH. Prenatal docosahexaenoic acid supplementation has long-term effects on childhood behavioral and brain responses during performance on an inhibitory task","volume":"25","author":"Gustafson","year":"2022","journal-title":"Nutr. Neurosci."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0039","first-page":"280","article-title":"Essential n\u22123 fatty acids in pregnant women and early visual acuity maturation in term infants","volume":"79","author":"Lauritzen","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0040","first-page":"e597","article-title":"Maternal DHA supplementation and infant attention","volume":"113","author":"Colombo","year":"2004","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0041","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11745-006-3007-3","article-title":"A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age","volume":"42","author":"Judge","year":"2007","journal-title":"Lipids"},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0042","doi-asserted-by":"crossref","first-page":"F383","DOI":"10.1136\/fn.88.5.F383","article-title":"Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomized trial","volume":"88","author":"Malcolm","year":"2003","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0043","first-page":"1385","article-title":"Prenatal maternal docosahexaenoic acid intake and infant information processing at 4.5 mo and 9 mo: a longitudinal study","volume":"109","author":"Rees","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0044","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/ajcn\/63.5.687","article-title":"Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia","volume":"63","author":"Carlson","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0045","first-page":"261","article-title":"Effects of supplementation of term infant formula with DHA (0.35%) or with DHA (0.36%) and AA (0.72%) on visual acuity development compared with breastfeeding","volume":"67","author":"Birch","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0046","first-page":"386","article-title":"Effects of a supplement with AA and DHA on visual acuity in preterm infants","volume":"25","author":"Fang","year":"2005","journal-title":"J. Perinatol."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0047","first-page":"153","article-title":"Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin","volume":"34","author":"Carlson","year":"1993","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0048","first-page":"F35","article-title":"DHA-enriched formula and visual acuity in preterm infants","volume":"93","author":"Smithers","year":"2008","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0049","first-page":"280","article-title":"Maternal fish oil supplementation during lactation and visual development of term infants","volume":"79","author":"Lauritzen","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0050","first-page":"556","article-title":"Lower incidence of necrotizing enterocolitis in preterm infants fed a DHA- and AA-supplemented formula","volume":"68","author":"Carlson","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0051","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-3476(96)70052-5","article-title":"A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until 9 months","volume":"129","author":"Werkman","year":"1996","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0052","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1542\/peds.108.2.359","article-title":"Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial","volume":"108","author":"O'Connor","year":"2001","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.plefa.2025.102686_bib0053","first-page":"1024","article-title":"Does dietary supplementation of DHA and AA improve visual development in preterm infants?","volume":"91","author":"Van Wezel-Meijler","year":"2002","journal-title":"Acta Paediatr."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0054","article-title":"Evaluation of the retinopathy of prematurity activity scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial","volume":"7","author":"Pivodic","year":"2022","journal-title":"BMJ Open Ophthalmol."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0055","first-page":"31","article-title":"Fatty acid profile of buccal cheek cell phospholipids as an index for dietary intake of docosahexaenoic acid in preterm infants","volume":"34","author":"Hoffman","year":"1999","journal-title":"Lipids"},{"issue":"Suppl","key":"10.1016\/j.plefa.2025.102686_bib0056","first-page":"S207","article-title":"Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants","volume":"34","author":"Jensen","year":"1999","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0057","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ajcn\/71.1.120","article-title":"A randomized trial of different ratios of linoleic to alpha-linolenic acid in the diet of term infants: effects on visual function and growth","volume":"71","author":"Makrides","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"issue":"11","key":"10.1016\/j.plefa.2025.102686_bib0058","first-page":"745","article-title":"Visual function and development in term infants fed formulas supplemented with docosahexaenoic acid and gamma-linolenic acid","volume":"52","author":"H\u00f8rby","year":"1998","journal-title":"Eur. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0059","first-page":"687","article-title":"Prestidge C. Visual acuity and fatty acid status of term infants fed formula supplemented with egg yolk lecithin","volume":"32","author":"Birch","year":"1992","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.earlhumdev.2006.11.003","article-title":"Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula","volume":"83","author":"Birch","year":"2007","journal-title":"Early Hum. Dev."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0061","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0022-3476(97)70154-9","article-title":"Effects of dietary linoleic\/alpha-linolenic acid ratio on growth and visual function in term infants","volume":"131","author":"Jensen","year":"1997","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0062","first-page":"57","article-title":"Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation","volume":"62","author":"Makrides","year":"1995","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0063","first-page":"540","article-title":"Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development","volume":"31","author":"Hoffman","year":"2000","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"9","key":"10.1016\/j.plefa.2025.102686_bib0064","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/jn\/134.9.2307","article-title":"Maturation of visual acuity is accelerated in breast-fed term infants fed baby food containing DHA-enriched egg yolk","volume":"134","author":"Hoffman","year":"2004","journal-title":"J. Nutr."},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0065","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/ajcn\/81.4.871","article-title":"Visual maturation of term infants fed long-chain polyunsaturated fatty acid\u2013supplemented or control formula for 12 mo","volume":"81","author":"Birch","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0066","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3945\/ajcn.2009.28557","article-title":"The DIAMOND Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid","volume":"91","author":"Birch","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.plefa.2025.102686_bib0067","first-page":"807","article-title":"The protective effect of dietary supplementation with natural n-3 polyunsaturated fatty acids on the visual acuity of school-age children with lower intelligence quotients or attention deficit hyperactivity disorder","volume":"6","author":"Wu","year":"2015","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0068","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jcpp.12614","article-title":"Omega 3\/6 fatty acids for reading in children: a randomized, double-blind, placebo-controlled trial in 9-year-old mainstream schoolchildren in Sweden","volume":"58","author":"John","year":"2017","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0069","first-page":"698","article-title":"Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder","volume":"63","author":"Hariri","year":"2012","journal-title":"Int. J. Food Sci. Nutr."},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0070","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/ajcn\/87.5.1170","article-title":"Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n\u22123 fatty acids containing phospholipids","volume":"87","author":"Vaisman","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0071","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpeds.2010.06.056","article-title":"Long-term effects of prenatal omega-3 fatty acid intake on visual function in school-age children","volume":"158","author":"Jacques","year":"2011","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0072","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3945\/ajcn.115.114710","article-title":"Long-term effect of high-dose supplementation with DHA on visual function at school age in children born at <33 wk gestational age: results from a follow-up of a randomized controlled trial","volume":"103","author":"Molloy","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0073","doi-asserted-by":"crossref","first-page":"313","DOI":"10.23736\/S0026-4946.18.04975-7","article-title":"Early monitoring of fatty acid profile in children with attention deficit and\/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids","volume":"71","author":"Checa-Ros","year":"2019","journal-title":"Minerva Pediatr."},{"key":"10.1016\/j.plefa.2025.102686_bib0074","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.earlhumdev.2017.09.015","article-title":"Omega-3 and -6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: a randomized controlled trial","volume":"115","author":"Boone","year":"2017","journal-title":"Early Hum. Dev."},{"issue":"8","key":"10.1016\/j.plefa.2025.102686_bib0075","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1212\/WNL.57.8.1488","article-title":"Fish oil supplementation improves visual evoked potentials in children with phenylketonuria","volume":"57","author":"Beblo","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0076","first-page":"200","article-title":"Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients","volume":"55","author":"Guti\u00e9rrez-Mata","year":"2012","journal-title":"Rev. Neurol."},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0077","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/ajcn\/nqz018","article-title":"The Kansas University DHA Outcomes Study (KUDOS) clinical trial: long-term behavioral follow-up of the effects of prenatal DHA supplementation","volume":"109","author":"Colombo","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"issue":"3 Pt 1","key":"10.1016\/j.plefa.2025.102686_bib0078","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1542\/peds.112.3.e177","article-title":"Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age","volume":"112","author":"Auestad","year":"2003","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.plefa.2025.102686_bib0079","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3390\/nu10121944","article-title":"Determinants of plasma docosahexaenoic acid levels and their relationship to neurological and cognitive functions in PKU patients: a double blind randomized supplementation study","volume":"10","author":"Demmelmair","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/nu12010248","article-title":"Microencapsulated tuna oil results in higher absorption of DHA in toddlers","volume":"12","author":"Fard","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0081","first-page":"311","article-title":"Effect of using a combination of lid wipes, eye drops, and omega-3 supplements on meibomian gland functionality in patients with lipid deficient\/evaporative dry eye","volume":"41","author":"Korb","year":"2015","journal-title":"Eye Contact Lens"},{"issue":"18","key":"10.1016\/j.plefa.2025.102686_bib0082","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa1709691","article-title":"n\u20133 fatty acid supplementation for the treatment of dry eye disease","volume":"378","author":"Asbell","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0083","first-page":"69","article-title":"Short-term omega 3 fatty acids treatment for dry eye in young and middle-aged visual display terminal users","volume":"41","author":"Bhargava","year":"2015","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.plefa.2025.102686_bib0084","first-page":"903","article-title":"Epithelial healing and visual outcomes of patients using omega-3 oral nutritional supplements before and after photorefractive keratectomy: a pilot study","volume":"7","author":"Ong","year":"2013","journal-title":"Clin. Ophthalmol."},{"issue":"10","key":"10.1016\/j.plefa.2025.102686_bib0085","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/ICO.0b013e318299549c","article-title":"Long-term supplementation with n-6 and n-3 PUFAs improves moderate-to-severe keratoconjunctivitis sicca: a randomized double-blind clinical trial","volume":"32","author":"Sheppard","year":"2013","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.plefa.2025.102686_bib0086","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archopht.122.9.1297","article-title":"Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment","volume":"122","author":"Berson","year":"2004","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0087","article-title":"Omega-3 fatty acids modify human cortical visual processing\u2014a double-blind, crossover study","volume":"6","author":"Bauer","year":"2011","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0088","first-page":"161","article-title":"Effects of dietary supplementation with a combination of fish oil, bilberry extract, and lutein on subjective symptoms of asthenopia in humans","volume":"34","author":"Kawabata","year":"2013","journal-title":"Biomed. Res."},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0089","first-page":"427","article-title":"The dry eye assessment and management (DREAM) extension study: a randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease","volume":"127","author":"Hussain","year":"2020","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0090","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4103\/IJO.IJO_2789_22","article-title":"Omega-3 fatty acids supplements for dry eye - are they effective or ineffective?","volume":"71","author":"Bhargava","year":"2023","journal-title":"Indian J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.plefa.2025.102686_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108178","article-title":"A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on neural processing speed and efficiency","volume":"9","author":"Bovier","year":"2014","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0092","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/aos.12629","article-title":"A two-year follow-up of oral antioxidant supplementation in primary open-angle glaucoma: an open-label, randomized, controlled trial","volume":"93","author":"Garcia-Medina","year":"2015","journal-title":"Acta Ophthalmol."},{"issue":"15","key":"10.1016\/j.plefa.2025.102686_bib0093","first-page":"8592","article-title":"An oral polyphenol formulation to modulate the ocular surface inflammatory process and to improve the symptomatology associated with dry eye disease","volume":"23","author":"Ng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0094","first-page":"527","article-title":"Effect of docosahexaenoic acid supplementation on the macular function of patients with best vitelliform macular dystrophy: randomized clinical trial","volume":"46","author":"Querques","year":"2011","journal-title":"Can. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.plefa.2025.102686_bib0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S0007114512000566","article-title":"Supplementation with DHA and the psychological functioning of young adults","volume":"109","author":"Benton","year":"2013","journal-title":"Br. J. Nutr."},{"issue":"8 Suppl","key":"10.1016\/j.plefa.2025.102686_bib0096","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/00006982-200512001-00023","article-title":"A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa","volume":"25","author":"Birch","year":"2005","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.plefa.2025.102686_bib0097","first-page":"2484","article-title":"The association of statin use with age-related macular degeneration progression: the age-related Eye Disease Study 2 report number 9","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.plefa.2025.102686_bib0098","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1167\/iovs.15-17786","article-title":"Docosahexaenoic acid slows visual field progression in X-linked retinitis pigmentosa: ancillary outcomes of the DHAX Trial","volume":"56","author":"Hoffman","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0099","first-page":"621","article-title":"Effect of dietary supplementation with lutein, zeaxanthin and \u03c9-3 on macular pigment: a randomized clinical trial","volume":"38","author":"Ma","year":"2010","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0100","first-page":"85","article-title":"The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population","volume":"15","author":"Stough","year":"2011","journal-title":"Nutr. Neurosci."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0101","first-page":"109","article-title":"A randomized study of nutritional supplementation in patients with unilateral wet age-related macular degeneration: the Nutritional AMD Treatment 2 study","volume":"229","author":"Souied","year":"2013","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0102","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/ICO.0000000000000386","article-title":"Effect of oral omega-3 fatty acid supplementation on contrast sensitivity in patients with moderate meibomian gland dysfunction: a prospective placebo-controlled study","volume":"34","author":"Bhargava","year":"2015","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.plefa.2025.102686_bib0103","first-page":"e540","article-title":"Effects of 2-year nutritional supplementation on progression of age-related macular degeneration","volume":"89","author":"Weigert","year":"2011","journal-title":"Acta Ophthalmol."},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0104","first-page":"817","article-title":"Association of mortality with ocular diseases and visual impairment in the age-related Eye Disease study 2 (AREDS2): AREDS2 report number 13","volume":"124","author":"Chew","year":"2017","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.plefa.2025.102686_bib0105","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3129\/i07-116","article-title":"Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration","volume":"42","author":"Chong","year":"2007","journal-title":"Can. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.plefa.2025.102686_bib0106","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s11745-007-3098-5","article-title":"Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food","volume":"42","author":"Arterburn","year":"2007","journal-title":"Lipids"},{"issue":"9","key":"10.1016\/j.plefa.2025.102686_bib0107","first-page":"6112","article-title":"Effects of lutein and docosahexaenoic acid supplementation on macular pigment optical density in a randomized controlled trial","volume":"54","author":"Mares-Perlman","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0108","first-page":"456","article-title":"A deep phenotype association study reveals specific phenotype associations with genetic variants in age-related macular degeneration: age-related Eye Disease Study 2 (AREDS2) report No. 14","volume":"124","author":"Chew","year":"2017","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.plefa.2025.102686_bib0109","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.ophtha.2013.01.005","article-title":"Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study","volume":"120","author":"Souied","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.plefa.2025.102686_bib0110","first-page":"666","article-title":"Visual acuity outcomes after anti-VEGF treatment for neovascular age-related macular degeneration: AREDS2 report number 19","volume":"3","author":"Chew","year":"2019","journal-title":"Ophthalmol. Retina"},{"issue":"7","key":"10.1016\/j.plefa.2025.102686_bib0111","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jamaophthalmol.2013.4412","article-title":"Age-related Eye Disease Study 2 Research group. Lutein\/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4","volume":"131","year":"2013","journal-title":"JAMA Ophthalmol."},{"issue":"13","key":"10.1016\/j.plefa.2025.102686_bib0112","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.1167\/iovs.15-17586","article-title":"Oral lutein supplementation enhances macular pigment density and contrast sensitivity but not in combination with polyunsaturated fatty acids","volume":"56","author":"Loughman","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.plefa.2025.102686_bib0113","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00417-011-1780-z","article-title":"Long-term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study","volume":"249","author":"Weigert","year":"2011","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.plefa.2025.102686_bib0114","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","article-title":"Secondary analyses of the effects of lutein\/zeaxanthin on age-related macular degeneration progression: AREDS2 Report No. 3","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmol."},{"issue":"11","key":"10.1016\/j.plefa.2025.102686_bib0115","first-page":"2335","article-title":"The role of macular xanthophylls and omega-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: AREDS2 Report No. 20","volume":"121","author":"SanGiovanni","year":"2014","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.plefa.2025.102686_bib0116","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ophtha.2019.06.004","article-title":"No CFH or ARMS2 interaction with omega-3 fatty acids, low versus high zinc, or \u03b2-carotene versus lutein and zeaxanthin on progression of age-related macular degeneration in the age-related Eye Disease Study 2: AREDS2 Report No. 18","volume":"126","author":"van Asten","year":"2019","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0117","article-title":"CFH Y402H and ARMS2 A69S polymorphisms and oral supplementation with docosahexaenoic acid in neovascular age-related macular degeneration patients: the NAT2 study","volume":"10","author":"Souied","year":"2015","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.plefa.2025.102686_bib0118","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/13816810.2018.1484931","article-title":"Investigation of the effect of dietary docosahexaenoic acid (DHA) supplementation on macular function in subjects with autosomal recessive Stargardt macular dystrophy","volume":"39","author":"MacDonald","year":"2018","journal-title":"Ophthalmic. Genet."},{"issue":"6","key":"10.1016\/j.plefa.2025.102686_bib0119","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/IAE.0000000000002114","article-title":"Three-year outcomes in a randomized single-blind controlled trial of intravitreal ranibizumab and oral supplementation with docosahexaenoic acid and antioxidants for diabetic macular edema","volume":"39","author":"Lafuente","year":"2019","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.plefa.2025.102686_bib0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0008-4182(02)80042-4","article-title":"La phototh\u00e9rapie dynamique de la d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l'\u00e2ge avec ou sans th\u00e9rapie aux antioxydants","volume":"37","author":"Scorolli","year":"2002","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.plefa.2025.102686_bib0121","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2415-7-3","article-title":"TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD","volume":"7","author":"Cangemi","year":"2007","journal-title":"BMC Ophthalmol."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327825000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327825000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T10:45:20Z","timestamp":1756982720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327825000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":121,"alternative-id":["S0952327825000237"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2025.102686","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of n-3 polyunsaturate fatty acids supplementation on visual health throughout the life cycle: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2025.102686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102686"}}